Training activity information
Details
Clinically interpret results of chimerism analysis to assess and monitor patients post HSCT
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Involvement of the wider multidisciplinary team and other specialties
- Local protocols for the clinical and laboratory monitoring of patients who have received HSCT
- Conditioning regimens and applicability of chimerism analysis
- Immunosuppression regimes
- Principles of methods employed for post-transplant monitoring including sensitivity and specificity
- Cell lineage analysis
- National guidelines for chimerism analysis
- Applicability of chimerism analysis for malignant and non-malignant conditions
- HSCT complications
- Patient centred care and support impact of the chimerism results for the patient including treatment options
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 3 |
Outcome
Perform clinical and laboratory monitoring of patients who have received HSCT. |
| # 4 |
Outcome
Practice effectively in partnership with other clinical specialisms and the wider multidisciplinary team in the investigation of HSCT to deliver safe and effective patient care. |